These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 2179367)
1. Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma. Pierson WE; LaForce CF; Bell TD; MacCosbe PE; Sykes RS; Tinkelman D J Allergy Clin Immunol; 1990 Mar; 85(3):618-26. PubMed ID: 2179367 [TBL] [Abstract][Full Text] [Related]
2. Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction. European Study Group. Paggiaro PL; Giannini D; Di Franco A; Testi R Eur Respir J; 1996 Aug; 9(8):1689-95. PubMed ID: 8866596 [TBL] [Abstract][Full Text] [Related]
3. The use of a single daily theophylline dose and metered-dose albuterol in asthma treatment. Busse WW; Smith A; Bush RK J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 1):577-82. PubMed ID: 3771949 [TBL] [Abstract][Full Text] [Related]
4. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease. Broseghini C; Testi R; Polese G; Tosatto R; Rossi A Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852 [TBL] [Abstract][Full Text] [Related]
5. Oral fenoterol versus sustained release theophylline in adult asthmatics. Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437 [TBL] [Abstract][Full Text] [Related]
6. Salmeterol vs theophylline: sleep and efficacy outcomes in patients with nocturnal asthma. Wiegand L; Mende CN; Zaidel G; Zwillich CW; Petrocella VJ; Yancey SW; Rickard KA Chest; 1999 Jun; 115(6):1525-32. PubMed ID: 10378544 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study. Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581 [TBL] [Abstract][Full Text] [Related]
8. Salmeterol versus theophylline in the treatment of asthma. Pollard SJ; Spector SL; Yancey SW; Cox FM; Emmett A Ann Allergy Asthma Immunol; 1997 May; 78(5):457-64. PubMed ID: 9164358 [TBL] [Abstract][Full Text] [Related]
9. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303 [TBL] [Abstract][Full Text] [Related]
10. Relative efficacy of maintenance therapy with theophylline, inhaled albuterol, and the combination for chronic asthma. Joad JP; Ahrens RC; Lindgren SD; Weinberger MM J Allergy Clin Immunol; 1987 Jan; 79(1):78-85. PubMed ID: 3805550 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of intravenously administered theophylline in children hospitalized with severe asthma. Carter E; Cruz M; Chesrown S; Shieh G; Reilly K; Hendeles L J Pediatr; 1993 Mar; 122(3):470-6. PubMed ID: 8441108 [TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled comparison of the efficacy of standard and individually titrated doses of theophylline in patients with chronic asthma. Barlow TJ; Graham P; Harris JM; Hartley JP; Turton CW Br J Dis Chest; 1988 Jul; 82(3):251-61. PubMed ID: 3073805 [TBL] [Abstract][Full Text] [Related]
14. Controlled release salbutamol tablets versus sustained release theophylline tablets in the control of reversible obstructive airways disease. Vyse T; Cochrane GM J Int Med Res; 1989; 17(1):93-8. PubMed ID: 2651178 [TBL] [Abstract][Full Text] [Related]
15. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Busse W; Levine B; Andriano K; Lavecchia C; Yegen U Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial. Goldstein MF; Chervinsky P Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074 [TBL] [Abstract][Full Text] [Related]
17. Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma. Martin RJ; Kraft M; Beaucher WN; Kiechel F; Sublett JL; LaVallee N; Shilstone J Ann Allergy Asthma Immunol; 1999 Aug; 83(2):121-6. PubMed ID: 10480584 [TBL] [Abstract][Full Text] [Related]
18. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma. D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853 [TBL] [Abstract][Full Text] [Related]
19. Is a uniform round-the-clock theophylline blood level necessary for optimal asthma therapy in the adolescent patient? Bierman CW; Pierson WE; Shapiro GG; Furukawa CT Am J Med; 1988 Jul; 85(1B):17-20. PubMed ID: 3041822 [TBL] [Abstract][Full Text] [Related]
20. A comparison of inhaled ipratropium, oral theophylline plus inhaled beta-agonist, and the combination of all three in patients with COPD. Karpel JP; Kotch A; Zinny M; Pesin J; Alleyne W Chest; 1994 Apr; 105(4):1089-94. PubMed ID: 8162730 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]